<SEC-DOCUMENT>0001213900-20-009372-index.html : 20200417
<SEC-HEADER>0001213900-20-009372.hdr.sgml : 20200417
<ACCEPTANCE-DATETIME>20200416182421
ACCESSION NUMBER:		0001213900-20-009372
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20200416
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200417
DATE AS OF CHANGE:		20200416

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Inmune Bio, Inc.
		CENTRAL INDEX KEY:			0001711754
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				475205835
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38793
		FILM NUMBER:		20797348

	BUSINESS ADDRESS:	
		STREET 1:		1200 PROSPECT STREET
		STREET 2:		SUITE 525
		CITY:			LA JOLLA
		STATE:			CA
		ZIP:			92037
		BUSINESS PHONE:		8589643720

	MAIL ADDRESS:	
		STREET 1:		1200 PROSPECT STREET
		STREET 2:		SUITE 525
		CITY:			LA JOLLA
		STATE:			CA
		ZIP:			92037
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea120711-8k_inmunebioinc.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
Document 1 - file: ea120711-8k_inmunebioinc.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ea120711ex1-1_inmunebio.htm
<DESCRIPTION>AT-THE-MARKET SALES AGREEMENT, DATED APRIL 16, 2020, BETWEEN THE COMPANY AND BTIG
<TEXT>
Document 2 - file: ea120711ex1-1_inmunebio.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>ea120711ex5-1_inmunebio.htm
<DESCRIPTION>OPINION OF SICHENZIA ROSS FERENCE LLP
<TEXT>
Document 3 - file: ea120711ex5-1_inmunebio.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 4 - file: logo.jpg

</DOCUMENT>
</SEC-DOCUMENT>